Chemoinformaics analysis of (+)-syringaresinol-di-o-beta-d-glucoside
| Molecular Weight | 742.724 | nRot | 12 |
| Heavy Atom Molecular Weight | 696.356 | nRig | 33 |
| Exact Molecular Weight | 742.268 | nRing | 6 |
| Solubility: LogS | -3.236 | nHRing | 4 |
| Solubility: LogP | -0.365 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 52 | No. of Aromatic Carbocycles | 2 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 12 |
| nHA | 18 | APOL | 101.888 |
| nHD | 8 | BPOL | 63.5075 |
| QED | 0.119 |
| Synth | 5.139 |
| Natural Product Likeliness | 1.078 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.995 |
| HIA | 0.88 |
| CACO-2 | -6.442 |
| MDCK | 0.00009 |
| BBB | 0.127 |
| PPB | 0.400034 |
| VDSS | 0.43 |
| FU | 0.277161 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.59 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.708 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.096 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.066 |
| CL | 1.451 |
| T12 | 0.431 |
| hERG | 0.641 |
| Ames | 0.084 |
| ROA | 0.009 |
| SkinSen | 0.609 |
| Carcinogencity | 0.034 |
| EI | 0.008 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.474 |
| Antiviral | Yes |
| Prediction | 0.896524 |